Last year, Haemonetics Corp generated 563.73M USD for its biggest-performing segment, Plasma products and services. The United States made the largest contribution, accounting for 1.01B USD last year. For the latest quarter, Haemonetics Corp reported the revenue of 148.32M USD for the period ending 2023-04-01, which came from the top-performing segment, Plasma products and services. United States contributed the highest revenue, at 257.84M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Plasma products and services

HospitalHospital products and services

Blood Center products and services

FY2023

FY2022

FY2021

FY2020

FY2019

Plasma products and services

563.73M(48.24%)

427.61M(43.05%)

414.27M(47.59%)

537.23M(54.35%)

501.84M(51.87%)

HospitalHospital products and services

378.11M(32.35%)

329.43M(33.17%)

216.58M(24.88%)

198.42M(20.07%)

196.54M(20.31%)

Blood Center products and services

226.82M(19.41%)

236.16M(23.78%)

239.61M(27.53%)

252.83M(25.58%)

269.20M(27.82%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

Europe

Asia

Japan

other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

1.01B(74.29%)

970.01M(74.10%)

842.90M(72.13%)

639.32M(64.37%)

522.61M(60.04%)

646.20M(65.37%)

606.85M(62.72%)

Europe

175.66M(12.91%)

160.14M(12.23%)

156.68M(13.41%)

163.52M(16.46%)

159.08M(18.27%)

153.35M(15.51%)

164.50M(17.00%)

Asia

92.31M(6.78%)

107.54M(8.21%)

104.14M(8.91%)

110.80M(11.16%)

105.82M(12.16%)

109.30M(11.06%)

118.70M(12.27%)

Japan

62.41M(4.59%)

58.09M(4.44%)

61.30M(5.24%)

75.56M(7.61%)

77.68M(8.92%)

72.22M(7.31%)

69.91M(7.23%)

other

19.54M(1.44%)

13.28M(1.01%)

3.65M(0.31%)

3.99M(0.40%)

5.28M(0.61%)

7.42M(0.75%)

7.62M(0.79%)